NeuroStar pioneered the Transcranial Magnetic Stimulation (TMS) for clinical use and reimbursement market with the first FDA cleared depression treatment since 2008.
Over one million treatments delivered nationwide.
#1 TMS Choice of Doctors.
Request an appointment today!
Over one million treatments delivered nationwide.
#1 TMS Choice of Doctors.
Request an appointment today!
Location: United States, Pennsylvania, Malvern
Employees: 51-200
Phone: +1 877-600-7555
Total raised: $15M
Founded date: 2003
Investors 2
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Ascension ... | ascensionv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.06.2017 | Series G | $15M | - |
Mentions in press and media 11
| Date | Title | Description |
| 04.06.2024 | The TMS Center of New Jersey Introduces NeuroStar Advanced Therapy for Adolescent Depression Treatment | The TMS Center of New Jersey has been treating adults with depression since 2010 and now offers adolescent treatment TINTON FALLS, NEW JERSEY, UNITED STATES, June 4, 2024 /EINPresswire.com/ -- The TMS Center of New Jersey, a leading provide... |
| 24.05.2024 | Learning to Achieve Wellness Celebrates Neuronetics' FDA Clearance for TMS device to Treat Adolescent Depression | Learning to Achieve Wellness Logo 83% of patients who complete Transcranial Magnetic Stimulation treatment experience measurable relief and 62% experience full remission of depression symptoms BRANDON, FLORIDA, UNITED STATES, May 24, 2024 /... |
| 20.05.2024 | Humana Becomes First Insurer to Cover TMS Therapy for Adolescent Depression | What You Should Know: – Neuronetics, Inc. and Humana announce a significant step forward in adolescent mental healthcare. This collaboration offers new hope for young people struggling with major depressive disorder (MDD) by making transcra... |
| 13.02.2024 | Neuronetics Launches Latest Evolution in its TrakStar Patient Data Management System | Advancements provide workflow efficiencies for NeuroStar TMS providers Neuronetics, Inc., a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from ne... |
| 10.04.2023 | NeuroStar Advanced Therapy Enhanced With Wi-Fi Capabilities | Fifth FDA clearance in less than two years offers greater connectivity and flexibility to improve the patient and provider experience Neuronetics, a commercial stage medical technology company focused on designing, developing, and marketing... |
| 13.02.2023 | Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners | NGS MAC Allows Non-Physician Practitioners with Autonomy to Prescribe TMS Neuronetics, a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who ... |
| 16.09.2022 | Cigna extends coverage for Brainsway’s brain stimulation device to treat OCD | Obsessive-Compulsive Disorder (OCD) has been ranked by the World Health Organization as one of the top 10 most debilitating medical conditions in terms of loss of income and decreased quality of life. The condition is a complex one that pre... |
| 28.06.2018 | Term Sheet — Thursday, June 28 | LYFTED Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Here are some additional notes: • In total, Lyft has raised $5.1 billion in funding. Lyft’s investors include AllianceBernstein, Baillie... |
| 06.06.2017 | Neuronetics Raises $15M Series G | Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS) therapy, announced today that it has closed on a $15 million Series G funding round from its existi... |
| 06.06.2017 | Neuronetics Raises $15M in Series G Equity Funding | Neuronetics, Inc., a Malvern, Pa.-based medical device company, closed on a $15m Series G funding. Backers included existing investors Accuitive Medical Ventures, GE Ventures, Interwest Partners, Industry Ventures, Investor Growth Capital, ... |
Show more